Pinned Tweet
Returns by year:
2017: 35.0%
2018: 0.2%
2019: 44.9%
2020: 21.6%
2021: 42.4%
2022: -16.8%
2023: 17.7%
2024: 22.2%
2025: 27.9%
1/1/2026 portfolio:
1. #GDWN Goodwin
2. $GOOG Alphabet
3. $AMZN Amazon
4. $COHR Coherent
5. $MSCI MSCI
6. $UBER Uber
7. $BABA Alibaba
8. $CRM Salesforce
9. $MA Mastercard
10. $HALO Halozyme Therapeutics
11. $V Visa
12. $AMAT Applied Materials
13. $MELI Mercado Libre
14. $NVDA Nvidia
15. #MSI MSI
16. $NOVO Novo Nordisk
17. $FOUR Shift 4 Payments
Now sold out of #MSI entirely. A multi-bagger but starting to feel like a jam tomorrow story
2025: +27.9%
- A pleasing year in the end. Flat until summer then up significantly between Sept-Nov (#GDWN plus US tech rally)
- 17 holdings. All US apart from #GDWN and #MSI. Barely touched pf in H2
- Return is well ahead of what has become my main benchmark, VUSA (the S&P 500 in £), +7%. S&P 500 in $ was +17%. £ knocked about 6/7% off my return
- Maintains my ARR since 2017 at about 21%
- Happy 2026 to all fellow investors!
2025 YTD: +3.9%
A positive week led by #GDWN (recently topped up and now largest holding) and US tech.
$NVO Novo Nordisk and weak $ combined have knocked about 12% pts off my pf this year. Hope and expect both factors to reverse!
About to head overseas temporarily for work so will reduce frequency of updates. In the meantime happy investing to all😉🤞
$NVO up 12% pre-market on this pill trial news. Finally some positive news for long suffering holders
$HALO Halozyme up 7% today after a significant beat and raise. Analysts raising PTs.
Regulatory and patent risks look well priced in even as it heads back to ATH of $70.
Amazing business model but a tiring hold as it is up and down massively on news flow.
YTD: +1.2%
Classic mid week highs followed by an end of week sell off.
Added to #GDWN after their results and it’s now my largest single holding. Excellently crafted report.
Finally added $MSCI to the portfolio on yesterday’s results sell off. A quality company at its lowest valuation for some time. Like every company it has its issues but is fundamentally well placed in a structurally attractive sector.
YTD: +2.4%
Up a fraction despite best efforts of my long held and now sold #AT. position. It does look cheap but I prefer not to hold after a downgrade and it does have a bit of debt. Should have acted earlier.
Sitting on 5% cash now with my eye on a new holding in $MSCI.
Bad luck to anyone camping today but at least lawn is happy!
YTD: +2.1%
Good week rounded off with a family lunch yesterday @langanslondon
Back into profit on some of my US tech holdings. Now up +20% on the #NVDA juggernaut.
Top sliced some #MSI to take back to medium sized position.
I don’t think GBP/USD strength in 2025 was driven by UK issues; I think it was largely about US trade policy.
But we look to have convergence of two things right now: 1. markets increasingly unfazed by tariff news flow and 2. evidence that UK economy is dipping.
Hard to see much further GBP/USD strength and I continue to be overweight high quality US equities in my portfolio.
Yes the US has its own debt issue but its growth is a bit of a get out of jail card. UK does not - yet - have a growth card to play.




